BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 17258500)

  • 1. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.
    Behr C; Sarthou JL; Rogier C; Trape JF; Dat MH; Michel JC; Aribot G; Dieye A; Claverie JM; Druihle P
    J Immunol; 1992 Nov; 149(10):3321-30. PubMed ID: 1431109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune responses to the Plasmodium falciparum antigen Pf155 RESA in adults with differential clinical conditions from an Indian zone where malaria is endemic.
    Biswas S; Rao DN; Roy A; Yadav RP; Ghosh SK; Kabilan L
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):219-27. PubMed ID: 8629049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
    Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
    J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response in mouse and malaria-exposed humans to peptides derived from Pf11-1, a highly repetitive megadalton protein of Plasmodium falciparum.
    Scherf A; Behr C; Sarthou JL; Pla M; Rogier C; Trape JF; da Silva LP; Dubois P
    Eur J Immunol; 1993 Jul; 23(7):1574-81. PubMed ID: 7686855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
    Das P; Grewal JS; Chauhan VS
    Trans R Soc Trop Med Hyg; 2010 May; 104(5):371-3. PubMed ID: 20116080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.
    Luty AJ; Lell B; Schmidt-Ott R; Lehman LG; Luckner D; Greve B; Matousek P; Herbich K; Schmid D; Ulbert S; Migot-Nabias F; Dubois B; Deloron P; Kremsner PG
    Eur Cytokine Netw; 1998 Dec; 9(4):639-46. PubMed ID: 9889408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
    Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
    Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
    Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas.
    Allsopp CE; Sanni LA; Reubsaet L; Ndungu F; Newbold C; Mwangi T; Marsh K; Langhorne J
    J Infect Dis; 2002 Mar; 185(6):812-9. PubMed ID: 11920299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum.
    Blum-Tirouvanziam U; Servis C; Habluetzel A; Valmori D; Men Y; Esposito F; Del Nero L; Holmes N; Fasel N; Corradin G
    J Immunol; 1995 Apr; 154(8):3922-31. PubMed ID: 7535817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein.
    Munesinghe DY; Clavijo P; Calle MC; Nussenzweig RS; Nardin E
    Eur J Immunol; 1991 Dec; 21(12):3015-20. PubMed ID: 1721025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial.
    Peduzzi E; Westerfeld N; Zurbriggen R; Pluschke G; Daubenberger CA
    Clin Immunol; 2008 May; 127(2):188-97. PubMed ID: 18337175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
    Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
    Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human immune response against the major merozoite surface antigen of Plasmodium falciparum.
    Crisanti A; Müller HM
    Parassitologia; 1991 Apr; 33(1):71-7. PubMed ID: 1841197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.